Raising Thousands for Lupus Research; Running the NYC Marathon for Life Without Lupus
November 4, 2019
Big thanks go to our Team Life Without Lupus, who put their heart and soul into running...
Stories & News
New Studies Suggest AVISE Lupus Test Improves Diagnosis of Disease
October 28, 2019
Because lupus is hard to diagnose, many patients don’t get the treatments they need, while others get...
Potential New Treatment in Phase III Trial
The Lupus Research Alliance is excited to announce that a potential new medicine for lupus—anifrolumab—reduced disease activity versus placebo...
10 Lupus Therapeutics Studies Currently Underway
TAK-079
A Study to Evaluate the Safety of TAK-079
PAISLEY-SLE
A Phase II study to evaluate a novel, oral therapy in SLE
ORKIDS
A...
Welcoming Daniel J. Wallace, MD to Lupus Therapeutics
The Lupus Research Alliance (LRA) affiliate Lupus Therapeutics is pleased to announce that Daniel J. Wallace, MD joins as...
Peer-to-Peer Involvement Advances Scientific Exploration
Many dynamics of lupus contribute to the fact that its complexities have eluded the scientific community—but new hope may...
Lupus Therapeutics Shifting the Paradigm
The Lupus Research Alliance (LRA)—going bold and thinking big—has once again shifted the status quo of lupus research by...
Epilepsy in People with Lupus
October 17, 2019
A new study published in the European Journal of Neurology showed that epilepsy is significantly more common...
High Levels of Interferon-Alpha Identifies Lupus Patients At Risk for Relapse
October 7, 2019
A new study published in Annals of the Rheumatic Diseases found that among people with lupus, high...
Why Don’t Half of People with Lupus Take Hydroxychlorine As Prescribed?
October 3, 2019
Hydroxychlorine is one of the most common treatments for lupus. But a new study published in The...
2019 Breaking Through Gala
The Lupus Research Alliance celebrates our annual Breaking through Lupus Gala on November 25, 2019 at the Ziegfeld Ballroom...
LRA Pleased to Share News of Lupus Nephritis Clinical Trial Launch
October 1, 2019
The Lupus Research Alliance is pleased to share news about the launch of EQUALISE, a Phase 1b...